🚨 Excited to share our work from @NorthwesternMed at #AACR26!
The PORTAL Study: Can recent cancer survivors safely receive liver transplants? 🐣

We’re prospectively enrolling patients with liver failure who had cancer within the past 5 years — including both remission (Cohort A) and active cancer (Cohort B) patients undergoing curative resection after transplant.

Tracking OS, DFS, graft survival & biomarkers (MRD, cfDNA) over 10 years 🧬
📍 @LurieCancer | Trial open & enrolling as of April 2026
#LiverTransplant #CancerSurvivor #Oncology #TransplantOncology​​​​​​​​​​​​​​​​ #ChaeLab
@AACR @NUFeinbergMed @oncodaily @OncoAlert @UNOSNews